Gestational diabetes mellitus (GDM) is the most common medical complication of
pregnancy. It is associated with maternal and neonatal adverse outcomes. Maintaining …

Polycystic ovary syndrome (PCOS) is associated with an increased risk of maternal
pregnancy and delivery complications. However, the impact of clinical features of PCOS and …

Objective Our objective was to formulate a clinical practice guideline for the management of
the pregnant woman with diabetes. Participants The Task Force was composed of a chair …

Polycystic ovary syndrome (PCOS) is now recognized to be the most common
endocrinopathy in women of reproductive age with a prevalence of 6.6–6.8%. PCOS, a …

BACKGROUND Metformin is generally considered a non-teratogenic drug; however, only a
few studies specifically designed to assess the rate of congenital anomalies after metformin …

Background Metformin is an effective oral anti-hyperglycemic agent that is widely used to
manage diabetes mellitus type 2 in the general population and more recently, in pregnancy …

Aim: The aim of the study is to evaluate the effects of metformin on pregnancy outcomes in
women with polycystic ovary syndrome (PCOS). Methods: We searched electronic …

Screening for polycystic ovary syndrome (PCOS) in antenatal care is inadequate, largely
owing to the lack of clarity around whether PCOS is an independent risk factor for pregnancy …

Polycystic ovary syndrome (PCOS) is associated with worsened pregnancy and infant
outcomes, higher body mass index (BMI), and longitudinal weight gain. Despite most of the …

Background. Women with polycystic ovary syndrome (PCOS) are at a high risk to develop
Gestational Diabetes mellitus (GDM). We hypothesized that metformin due to its metabolic …